Pulmonary hypertension (PH) is a complex and progressive disease characterized by elevated pulmonary arterial pressure and pulmonary vascular resistance. It is essential for healthcare professionals to understand its fundamentals to facilitate timely diagnosis and effective management.
PH involves the narrowing of the pulmonary arteries, leading to increased resistance to blood flow. This results in the right ventricle working harder to pump blood, leading to right heart failure if untreated. The precise pathophysiology varies with the type of PH, but often involves endothelial dysfunction, vasoconstriction, and vascular remodeling.
The World Health Organization (WHO) classifies PH into five groups based on etiology, clinical presentation, and hemodynamic characteristics. Diagnosis requires a high index of suspicion and is confirmed through right heart catheterization. Echocardiography serves as a crucial non-invasive screening tool.
Treatment strategies for PH are multifaceted and should be tailored to the individual patient. They include general measures, supportive treatments, and specific drug therapies. The choice of therapy depends on the WHO group of PH, the patient's functional class, and the risk stratification.
Despite advances in therapy, PH remains a disease with a significant morbidity and mortality rate. Regular follow-up with right heart catheterization and echocardiography is necessary to assess disease progression and response to therapy. Early referral to a specialized center is recommended for complex cases.
Understanding the fundamentals of PH is crucial for healthcare professionals. It allows for prompt diagnosis, effective management, and improved patient outcomes. As PH is a rapidly evolving field, staying updated with the latest research and treatment guidelines is essential.
1.
Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap
2.
Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal
3.
Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study
4.
The amount of liver tissue removed during gallbladder surgery has no discernible impact on overall survival.
5.
Long-Acting Interferon Therapy Approved for ET
1.
Molecular Network Mapping in Hematologic Disease
2.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
3.
Hematopoietic Stem Cell Clonal Dynamics Across the Lifespan
4.
Connected Hematology Laboratory Networks for Automated Cross-Institution Data Exchange
5.
Digital Oncology Ecosystems Integrating Longitudinal Patient Trajectories: Transforming Cancer Care through Data-Driven Innovation
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Common side effects of cancer treatment and how they are managed
3.
Clinical Excellence in Hematology
4.
Best Practices in Hematology
5.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation